Physician

Internal Medicine

Dr. James C. Sisson, MD

James Sisson is an expert in the field of Internal Medicine. He researched medicine at University of Michigan Medical School. James Sisson is a published doctor and has 25 publications published. The lastest was: 'Variation in the management of thyroid cancer.'

Publications

Variation in the management of thyroid cancer.
Referral Patterns for Patients with High-Risk Thyroid Cancer.
Factors that Influence Radioactive Iodine Use for Thyroid Cancer.
Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors.
Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinoma.
Response to Beasley CW, Moore WH, and Wagner LK.
Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation.
Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine.
A Proposition for the Use of Radioiodine in WDTC Management.
Radioiodine therapy and Graves' ophthalmopathy.
First description of parathyroid disease in multiple endocrine neoplasia 2A syndrome.
The so-called stunning of thyroid tissue.
Current trends in functional imaging of pheochromocytomas and paragangliomas.
Courses of malignant pheochromocytoma: implications for therapy.
Radiation-induced osteosarcoma and papillary carcinoma of the thyroid.
Choroidal and skin metastases from papillary thyroid cancer: case and a review of the literature.
Cryptococcal thyroiditis and hyperthyroidism.
Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?
Appearance of ectopic undescended inferior parathyroid adenomas on technetium Tc 99m sestamibi scintigraphy: a lesson from reoperative parathyroidectomy.
Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of 131I.
Radiopharmaceutical treatment of pheochromocytomas.
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
Practical dosimetry of 131I in patients with thyroid carcinoma.

Schools

University of Mi Med Sch
University Hospital Ann Arbor

Doctors Specialties

Internal Medicine

Accepted Insurances

Education

University of Michigan Hospitals and Health Centers
University of Michigan Medical School

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Neal E. Elkin, MD
	Dr. Robert F. Paretti, MD This Doctor is OpenDoctor Recommended.
	Dr. Howard Hu, MD This Doctor is OpenDoctor Recommended.
	Dr. Audrey L. Fan, MD This Doctor is OpenDoctor Recommended.
	Dr. Paul L. Fine, MD This Doctor is OpenDoctor Recommended.
	Dr. Pranab M. Barman, MD This Doctor is OpenDoctor Recommended.
	Dr. Leila O. Todd, MD This Doctor is OpenDoctor Recommended.
	Dr. Hilary A. Oman, MD This Doctor is OpenDoctor Recommended.
	Dr. Brett A. Izzo, MD This Doctor is OpenDoctor Recommended.
	Dr. Ronald B. Henckel, MD This Doctor is OpenDoctor Recommended.
	Dr. Sik K. Ang, MD
	Dr. Heather L. Simpkins, MD This Doctor is OpenDoctor Recommended.
	Dr. Maryann M. Shango, MD This Doctor is OpenDoctor Recommended.